Emerging drugs for eosinophilic esophagitis

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Eosinophilic esophagitis (EoE) is a rare but increasingly prevalent inflammatory esophageal disease.
• EoE presents with gastrointestinal symptoms and can lead to esophageal remodeling and strictures if untreated.
• Current treatments include dietary changes, proton pump inhibitors (PPIs), and swallowed corticosteroids, with limited options.

Purpose of the Study:

• To provide an updated review of current and investigational therapies for EoE.
• To discuss the progress in understanding EoE mechanisms and the development of targeted drugs.
• To highlight the need for further clinical trials and collaboration for new treatment options.

Main Methods:

• Literature search of PubMed for relevant articles.
• Identification of ongoing or completed clinical trials using clinicaltrials.gov and PharmaProjects database.
• Review and synthesis of current therapeutic strategies and emerging drug candidates for EoE.

Main Results:

• Significant advancements in understanding EoE pathophysiology have enabled the development of targeted therapies.
• Investigational drugs targeting specific EoE pathways show early promise, though controlled studies are limited.
• Multiple therapeutic targets have been identified, with several demonstrating efficacy in early investigations.

Conclusions:

• New targeted therapies for EoE are emerging, offering potential future treatment options.
• Further research, including defining appropriate trial outcome measures, is crucial.
• Collaboration among stakeholders is essential to advance EoE clinical trials and bring new therapies to practice.